Current Cancer Therapy Reviews

Editor-in-Chief

Yangchao Chen
School of Biomedical Sciences
Faculty of Medicine
The Chinese University of Hong Kong
Shatin
(Hong Kong)

Personal Subscription
Become EABM
Become Reviewer

Open Access Articles

A Comparison of Ultrasound and Fluoroscopy-guided Celiac Plexus Neurolysis in Patients with Pancreatic Cancer open Access plus

Volume: 16   Issue: 3
Pp: 246-252
Khadeja M. Elhossieny*, Waseem M. Seleem, Sherief Abd-Elsalam, Tamer Haydara and Nashwa Mohamed El Gharbawy
DOI:10.2174/1573394715666190904091145

New Researches about Combinatorial Therapeutic Regimen on Cancer Treatment open Access plus

Volume: 16   Issue: 2
Pp: 97-109
Xinjia He, Qiaqia He*, Lihua Wang and Xiaofei He
DOI:10.2174/1573394715666190906125014

Molecular Pathways, Screening and Follow-up of Colorectal Carcinogenesis: An Overview open Access plus

Volume: 16   Issue: 2
Pp: 88-96
Eskandar Taghizadeh, Seyed M.G. Hayat, Rhonda J. Rosengren , Daryoush Rostami, Hamed Abdolkarimi and Amirhossein Sahebkar *
DOI:10.2174/1573394715666190730111946

Development, Characterization and Anticancer Evaluation of Silver Nanoparticles from Dalbergia sissoo Leaf Extracts open Access plus

Volume: 16   Issue: 2
Pp: 145-151
Aakash Deep*, Mitali Verma, Rakesh K. Marwaha, Arun K. Sharma and Beena Kumari
DOI:10.2174/1573394715666190820150651

Dickkopf-1 and β-catenin as Biomarkers for Early Diagnosis of Hepatocellular Carcinoma open Access plus

Volume: 16   Issue: 2
Pp: 136-144
Amal A. Mohamed, Hala M. Ghanem, Maha M. Kamal, Rehab Ahmed, Naglaa K. Madkour, Dina Abdou, Soha M. Talima, Nehad Hawash and Sherief Abd-Elsalam*
DOI:10.2174/1573394715666191122094659

Demographic and Clinical Evaluation of Patients with Pancreatic Cancer in Mashhad University of Medical Sciences During 2002-2013 open Access plus

Volume: 16   Issue: 2
Pp: 127-135
Mina A. Rad, Azar Fanipakdel, Hassan Vossoughinia, Maliheh Dadgarmoghaddam, Benyamin Esmaeili, Amir H. Jafarian, Masoumeh Salari* and Abdollah Firoozi
DOI:10.2174/1573394715666190422123430

Brachial Plexopathy as a Complication of Radiotherapy: A Systematic Review open Access plus

Volume: 16   Issue: 2
Pp: 110-120
Dheyauldeen Shabeeb, Ahmed E. Musa , Mansoor Keshavarz, Ehsan Mihandoust, Gholamreza Hassanzadeh , Mohammad R. Hadian, Alireza Shirazi and Masoud Najafi *
DOI:10.2174/1573394715666190724102937

Virtual Screening of Novel Hybrid Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Exploring Multiple Targeted Cancer Therapy by an In Silico Approach open Access plus

Volume: 16   Issue: 1
Pp: 70-77
Ashish P. Shah* and Chhagan N. Patel
DOI:10.2174/1573394715666190618114748

Cancer Immunotherapy: An Effective Tool in Cancer Control and Treatment open Access plus

Volume: 16   Issue: 1
Pp: 62-69
Kawalpreet Kaur and Gopal L. Khatik*
DOI:10.2174/1573394715666190913184853

Drug Delivery Approaches for Doxorubicin in the Management of Cancers open Access plus

Volume: 16  
Pp: 1-13
Manish Vyas, Daniel Albert Simbo, Mohd. Mursalin, Vijay Mishra, Roqia Bashary and Gopal L. Khatik*
DOI:10.2174/1573394716666191216114950

Exploring Nanoemulsion for Liver Cancer Therapy open Access plus

Volume: 16  
Pp: 1-9
Vaseem Ansari*, Usama Ahmad, Tanmay Upadhyay, Nazneen Sultana and Juber Akhtar
DOI:10.2174/1573394716666200302123336

MiR-492 as an Important Biomarker for Early Diagnosis and Targeted Treatment in Different Cancers open Access plus

Volume: 16  
Pp: 1-7
Eskandar Taghizadeh*, Forough Taheri, Daryoush Rostami, Pedram Ghorbani Renani , Gordon A Ferns, Alireza Pasdar and Majid Ghayour Mobarhan
DOI:10.2174/1573394716666200309124048

Current and Emerging Therapy for Malignant Pleural Mesothelioma: Focus on CD26/Dipeptidyl Peptidase IV as a Therapeutic Target open Access plus

Volume: 13   Issue: 2
Pp: 76-88
Bently P. Doonan, Kei Ohnuma, Long H. Dang, Chikao Morimoto and Nam H. Dang*
DOI:10.2174/1573394713666170907160734

In Silico Study and Cytotoxicity of the Synthesized Open-chain Analogues of Antimycin A3 Against HEP-2 Laryngeal Cancer Cells open Access plus

Volume: 13   Issue: 2
Pp: 129-136
Ade Arsianti*, Fadilah Fadilah, Kusmardi Kusmardi, Gede Y. Sugiarta, Hiroki Tanimoto and Kiyomi Kakiuchi
DOI:10.2174/1573394713666170712113049

Non-Melanoma Skin Cancer – Overview open Access plus

Volume: 12   Issue: 3
Pp: 142-151
Kurian Joseph
DOI:10.2174/1573394713666161214124214

Roles of Tumor Microenvironment in Hepatocelluar Carcinoma open Access plus

Volume: 11   Issue: 2
Pp: 82-93
Haeng R. Seo
DOI:10.2174/1573394711666151022203313

Trends in Malignant Glioma Monoclonal Antibody Therapy open Access plus

Volume: 11   Issue: 2
Pp: 102-118
Ivan Chekhonin and Olga Gurina
DOI:10.2174/1573394711888150917142941

Mining the Dark Matter of the Cancer Proteome for Novel Biomarkers open Access plus

Volume: 9   Issue: 4
Pp: 265-277
Ana Paula Delgado, Pamela Brandao, Sheilin Hamid and Ramaswamy Narayanan
DOI:10.2174/1573394710666140313003905

Innate Immunity and Vaccine Adjuvants: From Concepts to the Development of a Unique Adjuvant System AS04 Used for the Formulation of a Human Papillomavirus (HPV) Vaccine open Access plus

Volume: 6   Issue: 2
Pp: 126-137
Nathalie Garcon and Oberdan Leo
DOI:10.2174/157339410791202574

Clinical Development of MET Targeted Therapy For Human Cancer open Access plus

Volume: 5   Issue: 4
Pp: 261-270
Nima Tirgan, Zhe Tang and Patrick C. Ma
DOI:10.2174/157339409789712708

Tumor Systems Need to be Rendered Usable for a New Action-Theoretical Abstraction: The Starting Point for Novel Therapeutic Options open Access plus

Volume: 5   Issue: 4
Pp: 232-242
Albrecht Reichle
DOI:10.2174/157339409789712690

Two Diseases with One Hit: Inhibiting a Potential Diabetes Target to Reduce Cancer Risk and to Improve Anti-Cancer Therapy open Access plus

Volume: 5   Issue: 2
Pp: 111-121
Nagendra K. Prasad
DOI:10.2174/157339409788166779

Runx1/AML1 is a Guardian of Hematopoietic Stem Cells open Access plus

Volume: 4   Issue: 3
Pp: 188-195
Lena Motoda, Motomi Osato and Yoshiaki Ito
DOI:10.2174/157339408785294302